Trifluoromethylation of alkyl electrophiles with <sup>11</sup>C- or <sup>18</sup>F-labeled fluoroform for PET applications.

Wang, Chao; DeMent, Paul; Jana, Susovan; Hong, Jinsoo; Pike, Victor W; Liu, Wei · Science · 2025

basic_science · Level V

Where this comes from

Abstract

Continued development of positron emission tomography (PET) tracers is essential for advancing molecular imaging in biomedical research and clinical diagnostics. A long-standing limitation in radiochemistry for PET imaging has been the lack of general methods for radiolabeling trifluoromethyl (CF<sub>3</sub>) groups at C(sp<sup>3</sup>) sites, despite their growing prevalence in bioactive molecules and radiopharmaceuticals. Here, we present a general approach for late-stage installation of either a [<sup>18</sup>F]CF<sub>3</sub> or [<sup>11</sup>C]CF<sub>3</sub> group at a C(sp<sup>3</sup>) site. This method leverages unusual copper-mediated radiotrifluoromethylation of alkyl halides and alkyl carboxylic acids by halogen atom transfer and photoredox catalysis, respectively. More than 50 complex molecules and pharmaceutical agents were efficiently labeled with fluorine-18 (<sup>18</sup>F) or carbon-11 (<sup>11</sup>C). Two long-sought-after radioligands, [<sup>18</sup>F]SL25.1188 and [<sup>18</sup>F]PS13, were synthesized, providing longer-lived <sup>18</sup>F analogs of their <sup>11</sup>C counterparts with great promise for human PET imaging.

Medical subject headings